Q4 2024 · 13F-HR
PERCEPTIVE ADVISORS LLCholdings as filed
Filed 2025-02-14 · accession 0001012975-25-000090
$3.63B
Reported value
99
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 925050106 | VRNA | VERONA PHARMA PLC | $296.8M | 8.18% | 6,392,106 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $266.8M | 7.35% | 3,478,888 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $228.4M | 6.29% | 24,245,952 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $206.0M | 5.68% | 3,680,473 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $205.1M | 5.65% | 2,619,977 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $163.6M | 4.51% | 22,112,266 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $140.7M | 3.88% | 1,718,417 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $107.6M | 2.97% | 1,288,328 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $106.3M | 2.93% | 6,349,220 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $102.3M | 2.82% | 1,329,735 | Common | SOLE |
| 228903100 | AORT | ARTIVION INC | $79.9M | 2.20% | 2,793,703 | Common | SOLE |
| G59665102 | MGTX | MEIRAGTX HLDGS PLC | $76.6M | 2.11% | 12,581,103 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $71.7M | 1.98% | 2,685,537 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $67.5M | 1.86% | 1,501,040 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $66.7M | 1.84% | 9,383,456 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $60.6M | 1.67% | 232,269 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $59.9M | 1.65% | 2,574,723 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $58.0M | 1.60% | 6,485,420 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $56.8M | 1.57% | 5,145,846 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $56.2M | 1.55% | 664,074 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $53.1M | 1.46% | 3,683,004 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $53.0M | 1.46% | 2,139,199 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $49.1M | 1.35% | 1,271,662 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $47.4M | 1.31% | 1,047,232 | Common | SOLE |
| 01438T106 | ALDX | ALDEYRA THERAPEUTICS INC | $46.3M | 1.28% | 9,275,851 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $43.8M | 1.21% | 817,895 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $41.5M | 1.14% | 67,471 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $40.1M | 1.10% | 995,894 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $38.5M | 1.06% | 500,000 | CALL | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $33.0M | 0.91% | 1,185,592 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $32.9M | 0.91% | 63,119 | Common | SOLE |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $32.3M | 0.89% | 5,360,858 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $31.2M | 0.86% | 2,130,020 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $30.9M | 0.85% | 2,362,279 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $28.5M | 0.79% | 1,486,508 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $27.6M | 0.76% | 6,906,646 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $25.6M | 0.71% | 6,774,348 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $23.4M | 0.64% | 290,659 | Common | SOLE |
| 63909J108 | NAUT | NAUTILUS BIOTECHNOLOGY INC | $21.2M | 0.58% | 12,594,211 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $21.1M | 0.58% | 1,441,249 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $19.8M | 0.55% | 125,000 | Common | SOLE |
| 45719W205 | IKT | INHIBIKASE THERAPEUTICS INC | $19.3M | 0.53% | 5,925,000 | Common | SOLE |
| 68572M106 | OBIO | ORCHESTRA BIOMED HLDGS INC | $18.4M | 0.51% | 4,592,556 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $17.4M | 0.48% | 73,338 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $17.2M | 0.47% | 750,000 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $16.4M | 0.45% | 845,567 | Common | SOLE |
| 45720N103 | INBX | INHIBRX BIOSCIENCES INC | $16.4M | 0.45% | 1,064,026 | Common | SOLE |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $15.3M | 0.42% | 890,280 | Common | SOLE |
| 10919W405 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $14.5M | 0.40% | 403,649 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $14.2M | 0.39% | 740,749 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES | $13.7M | 0.38% | 100,050 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $12.8M | 0.35% | 543,277 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $12.8M | 0.35% | 325,324 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $12.6M | 0.35% | 300,000 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $12.0M | 0.33% | 419,450 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $11.9M | 0.33% | 2,140,000 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $11.5M | 0.32% | 1,537,274 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $10.7M | 0.30% | 145,000 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $10.3M | 0.28% | 186,662 | Common | SOLE |
| 00534B100 | ADGM | ADAGIO MED HLDGS INC | $10.3M | 0.28% | 9,812,419 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $9.9M | 0.27% | 144,000 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $9.4M | 0.26% | 184,525 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $9.3M | 0.26% | 5,880,000 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $9.2M | 0.25% | 1,078,495 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $9.1M | 0.25% | 178,797 | Common | SOLE |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $8.6M | 0.24% | 1,004,439 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $6.2M | 0.17% | 330,614 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $6.1M | 0.17% | 744,035 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $5.9M | 0.16% | 65,153 | Common | SOLE |
| 75383L102 | RAPP | RAPPORT THERAPEUTICS INC | $5.5M | 0.15% | 311,551 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $5.3M | 0.14% | 500,000 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $4.8M | 0.13% | 378,584 | Common | SOLE |
| 15678C102 | CBLL | CERIBELL INC | $4.7M | 0.13% | 180,546 | Common | SOLE |
| 92536C103 | VERUEUR | VERU INC | $4.2M | 0.12% | 6,483,157 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $3.8M | 0.10% | 1,085,512 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $3.8M | 0.10% | 1,190,263 | Common | SOLE |
| 53566P109 | LCTX | LINEAGE CELL THERAPEUTICS IN | $3.6M | 0.10% | 7,236,843 | Common | SOLE |
| 09075X108 | — | BIODESIX INC | $3.3M | 0.09% | 2,173,880 | Common | SOLE |
| 04746L104 | — | ATHIRA PHARMA INC | $3.2M | 0.09% | 5,402,964 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $3.1M | 0.09% | 829,536 | Common | SOLE |
| 45256X103 | IBRX | IMMUNITYBIO INC | $3.1M | 0.09% | 1,221,734 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $2.8M | 0.08% | 197,108 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $2.6M | 0.07% | 12,757,562 | Common | SOLE |
| 92511W108 | — | VERRICA PHARMACEUTICALS INC | $2.3M | 0.06% | 3,249,669 | Common | SOLE |
| 34962G208 | FBRX | FORTE BIOSCIENCES INC | $2.2M | 0.06% | 95,742 | Common | SOLE |
| 810648105 | SCPH | SCPHARMACEUTICALS INC | $1.8M | 0.05% | 500,000 | Common | SOLE |
| 896438504 | TRIB | TRINITY BIOTECH PLC | $1.6M | 0.04% | 1,790,000 | Common | SOLE |
| 68232V884 | TRAW | TRAWS PHARMA INC | $1.5M | 0.04% | 164,157 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $1.1M | 0.03% | 238,000 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $920,114 | 0.03% | 139,835 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $804,000 | 0.02% | 100,000 | PUT | SOLE |
| 63009J107 | NBTX | NANOBIOTIX | $763,687 | 0.02% | 266,093 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $736,332 | 0.02% | 860,000 | Common | SOLE |
| 293602504 | ENSC | ENSYSCE BIOSCIENCES INC | $705,461 | 0.02% | 86,666 | Common | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $602,000 | 0.02% | 50,000 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $294,001 | 0.01% | 188,462 | Common | SOLE |
| 03837C106 | APYX | APYX MEDICAL CORPORATION | $237,000 | 0.01% | 150,000 | Common | SOLE |
| 76155X118 | RVMDW | REVOLUTION MEDICINES INC | $45,000 | 0.00% | 250,000 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $3,567 | 0.00% | 166,666 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.